ArticlePharmaceutical research2025

Revolutionizing Heart Failure Therapy: Harnessing IVT mRNA and Fusion Protein Technology to Prolong rhBNP Half-Life.

Yingyu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.